Jeffrey Sevigny insider trades

Open-market stock purchases and sales by Jeffrey Sevigny, Chief Medical Officer at Rapport Therapeutics, Inc, from SEC Form 4 filings since Feb 19, 2020.

Recent trades

DateStockTradeValue
Feb 2, 2026RAPP Rapport Therapeutics, IncBought (not open market)—

Companies traded

  • RAPP Rapport Therapeutics, Inc: other filings, last Feb 2, 2026
  • ABOS Acumen Pharmaceuticals, Inc: other filings, last Jun 15, 2022
  • PRVL Prevail Therapeutics Inc: other filings, last Jan 22, 2021

Get free alerts when Jeffrey Sevigny files a new trade →